These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38472311)

  • 1. Synthesis of biologically active Shiga toxins in cell-free systems.
    Ramm F; Kaser D; König I; Fellendorf J; Wenzel D; Zemella A; Papatheodorou P; Barth H; Schmidt H
    Sci Rep; 2024 Mar; 14(1):6043. PubMed ID: 38472311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic Effects of Recombinant StxA2-His in the Absence of Its Corresponding B-Subunit.
    Heinisch L; Krause M; Roth A; Barth H; Schmidt H
    Toxins (Basel); 2021 Apr; 13(5):. PubMed ID: 33925951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AB5 Preassembly Is Not Required for Shiga Toxin Activity.
    Pellino CA; Karve SS; Pradhan S; Weiss AA
    J Bacteriol; 2016 Jun; 198(11):1621-1630. PubMed ID: 27002129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of prokaryotic translation by the Shiga toxin enzymatic subunit.
    Skinner LM; Jackson MP
    Microb Pathog; 1998 Feb; 24(2):117-22. PubMed ID: 9480794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shiga toxin attacks bacterial ribosomes as effectively as eucaryotic ribosomes.
    Suh JK; Hovde CJ; Robertus JD
    Biochemistry; 1998 Jun; 37(26):9394-8. PubMed ID: 9649321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Free Systems Enable the Production of AB
    Ramm F; Jack L; Kaser D; Schloßhauer JL; Zemella A; Kubick S
    Toxins (Basel); 2022 Mar; 14(4):. PubMed ID: 35448842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.
    Henrique IM; Sacerdoti F; Ferreira RL; Henrique C; Amaral MM; Piazza RMF; Luz D
    Front Cell Infect Microbiol; 2022; 12():825856. PubMed ID: 35223548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga Toxin (Stx) Type 1a and Stx2a Translocate through a Three-Layer Intestinal Model.
    Bova RA; Lamont AC; Picou TJ; Ho VB; Gilchrist KH; Melton-Celsa AR
    Toxins (Basel); 2023 Mar; 15(3):. PubMed ID: 36977098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the interaction of Shiga toxin 2a with a C-terminal peptide of ribosomal P stalk proteins.
    Rudolph MJ; Davis SA; Tumer NE; Li XP
    J Biol Chem; 2020 Nov; 295(46):15588-15596. PubMed ID: 32878986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.
    Brigotti M; Carnicelli D; Arfilli V; Rocchi L; Ricci F; Pagliaro P; Tazzari PL; Vara AG; Amelia M; Manoli F; Monti S
    J Biol Chem; 2011 Oct; 286(40):34514-21. PubMed ID: 21832076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals.
    Mainil J
    Vet Res; 1999; 30(2-3):235-57. PubMed ID: 10367357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Cell-Based Assay for Detection of Active Shiga Toxins Produced by
    Hughes AC; Patfield S; Rasooly R; He X
    Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33126550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe and effective means of detecting and quantitating Shiga-like toxins in attomole amounts.
    Silva CJ; Erickson-Beltran ML; Skinner CB; Dynin I; Hui C; Patfield SA; Carter JM; He X
    Anal Chem; 2014 May; 86(10):4698-706. PubMed ID: 24761992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical Characterization of In vitro Reconstituted Biologically Active Recombinant Shiga Toxin.
    Chauhan V; Chauhan R; Sonkar P; Dhaked RK
    Protein Pept Lett; 2019; 26(3):227-234. PubMed ID: 30592251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-step purification and molecular characterization of functional Shiga toxin 2 variants from pathogenic Escherichia coli.
    He X; Quiñones B; McMahon S; Mandrell RE
    Toxins (Basel); 2012 Jul; 4(7):487-504. PubMed ID: 22852065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyzing of expression of novel polypeptide complexes consisting of Shiga toxin B subunit and Adherence Fimbriae of Escherichia coli based on in silico modeling.
    Noroozian Z; Oloomi M; Bouzari S
    J Mol Model; 2012 Sep; 18(9):4131-9. PubMed ID: 22527278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycolipid binding preferences of Shiga toxin variants.
    Karve SS; Weiss AA
    PLoS One; 2014; 9(7):e101173. PubMed ID: 24983355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shiga toxin mode of action in E. coli O157:H7 disease.
    Obrig TG
    Front Biosci; 1997 Dec; 2():d635-42. PubMed ID: 9392626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing
    McNichol BA; Bova RA; Torres K; Preston LN; Melton-Celsa AR
    Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33467588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxins and stx phages: highly diverse entities.
    Krüger A; Lucchesi PM
    Microbiology (Reading); 2015 Mar; 161(Pt 3):451-62. PubMed ID: 25479836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.